Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00132249 · ClinicalTrials.gov registry record
Vietnam Head Injury Study - Phase III
A clinical trial, sponsored by U.S. Army Medical Research and Development Command.
- Completed
- Registry status
- 254
- Enrollment target
NCT00132249: Completed study, sponsored by U.S. Army Medical Research and Development Command.
NCT00132249 is a clinical trial that has completed, run by U.S. Army Medical Research and Development Command. The registered enrollment target is 254 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00132249 has completed, sponsored by U.S. Army Medical Research and Development Command.
- COMPLETED
- Registry status
- 254 participants
- Enrollment target
Study Summary
The Vietnam Head Injury Study (VHIS)-Phase III is a prospective, long-term follow-up study of head-injured Vietnam veterans. The purpose of this research study is to determine the long-term consequences, if any, of head injury.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 254 participants |
| Start Date | 2004-04 |
| Est. Completion | 2010-09 |
What the finished NCT00132249 record still lists
NCT00132249 is an observational study that tracks outcomes without assigning an intervention. The registered 254 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00132249 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00132249 about?
NCT00132249 is a clinical study titled "Vietnam Head Injury Study - Phase III". The Vietnam Head Injury Study (VHIS)-Phase III is a prospective, long-term follow-up study of head-injured Vietnam veterans. The purpose of this research study is to determine the long-term consequences, if any, of head injury.
What is the current status of trial NCT00132249?
This trial is currently completed. The enrollment target is 254 participants. The study started on 2004-04. Estimated completion is 2010-09.
Who is sponsoring clinical trial NCT00132249?
This trial is sponsored by U.S. Army Medical Research and Development Command, which has 77 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04390737 · 254 participants · Phase 1
Evaluate the Safety and Clinical Activity of HH2853
- NCT04677647 · 254 participants · NA
OurChild: A Health IT Solution to Reduce Minority Health Disparities
- NCT05503797 · 254 participants · Phase 2
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- NCT06167317 · 254 participants · Phase 1
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia